Skeletal muscle is composed of fast- and slow-twitch fibres with distinctive physiological and metabolic properties. The
calmodulin-activated
serine/
threonine protein phosphatase calcineurin activates fast- to slow-twitch skeletal muscle remodelling through the induction of the slow-twitch skeletal muscle fibre gene expression programme, thereby enhancing
insulin-stimulated
glucose uptake and offering protection against dietary-induced
insulin resistance. Given the profound influence of skeletal muscle fibre type on
insulin-mediated responses, we determined whether the fast- to slow-twitch fibre-type transformation leads to alterations in
insulin-independent
glucose uptake in transgenic mice expressing a constitutively active form of
calcineurin (MCK-CnA* mice). We determined whether skeletal muscle remodelling by activated
calcineurin alters
glucose transport in response to the
AMP-activated protein kinase (AMPK) activator 5-aminoimidazole-4-carboxamide-beta-D-ribofuranoside (
AICAR) or muscle contraction, two divergent
insulin-independent activators of
glucose transport. While
insulin-stimulated
glucose transport was increased 52%, the
AICAR effect on
glucose transport was 27% lower in MCK-CnA* mice versus wild-type mice (P < 0.05). In contrast,
glucose transport was similar between genotypes after in vitro muscle contraction. Fibre-type transformation was associated with increased AMPKgamma1, decreased AMPKgamma3 and unchanged AMPKgamma2
protein expression between MCK-CnA* and wild-type mice (P < 0.05). The loss of
AICAR-mediated
glucose uptake is coupled to changes in the AMPK
isoform expression, suggesting fibre-type dependence of the
AICAR responses on
glucose uptake. In conclusion, improvements in skeletal muscle
glucose transport in response to
calcineurin-induced muscle remodelling are limited to
insulin action.